Adenovirus vector-based purging of multiple myeloma cells

Blood

Volumn 92, Issue 12, 1998, Pages 4591-4601

  Teoh, Gerrard ^b   Chen, Ling ^b   Urashima, Mitsuyoshi ^b   Tai, Yu Tzu ^b   Celi, Leo A ^b   Chen, Dongshu ^b   Chauhan, Dharminder ^b   Ogata, Atsushi ^b   Finberg, Robert W ^b   Webb, Lain J ^b   Kufe, Donald W ^b   Anderson, Kenneth C ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC TRANSDUCTION; HELA CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MYELOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION;

EID: 17444405911     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.12.4591.424k08_4591_4601     Document Type: Article

References (13)

1. Anderson KC: Who benefits from high dose therapy for multiple myeloma? J Clin Oncol 13:1291, 1995
2. Harousseau J-L, Attal M: The role of autologous hematopoietic stem cell transplantation in multiple myeloma. Semin Hematol 34:61, 1997
3. Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibet JG, Rossi JF, Casassus P, Maisonneuve H, Facon T, Ifrah N, Payen C, Bataille R: Autologous bone marrow transplantation versus conventional chemo-therapy in multiple myeloma: A prospective, randomized trial. N Engl J Med 335:91, 1996
4. Vesole DH, Tricot G, Jagannath S, Desikan KR, Siegel D, Bracy D, Miller L, Cheson B, Crowley J, Barlogie B: Autotransplants in multiple myeloma: What have we learned? Blood 88:838, 1996
5. Barlogie B, Jagannath S, Vesole DH, Naucke S, Cheson B, Mattox S, Bracy D, Salmon S, Jacobson J, Crowley J, Tricot G: Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma. Blood 89:789, 1997
6. Attal M, Payen C, Facon T, Michaux JL, Guilhot F, Moconduit M, Fuzibet JG, Caillot D, Corvaux V, Harousseau JL, Cahn JY, Grobois B, Stoppa AM, Ifrah N, Sotto JJ, Pignon B, Bataille R: Single versus double transplant in myeloma: A randomized trial of the Inter Groupe Francais du Myelome (IFM). Blood 90:418a, 1997 (abstr, suppl 1)
7. Giralt S, Weber D, Colome M, Dimopoulos M, Mehra R, Van Besien K, Gajewski J, Andersson B, Khouri I, Przepiorka D, von Wolff B, Delasalle K, Korbling M, Seong D, Alexanian R, Champlin R: Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescue. J Clin Oncol 15:667, 1997
8. Anderson KC, Barut BA, Ritz J, Freedman AS, Takvorian T, Rabinowe SN, Soiffer R, Heflin L, Coral F, Dear K, Mauch P, Nadler LM: Monoclonal antibody purged autologous bone marrow transplantation therapy for multiple myeloma. Blood 77:712, 1991
9. Anderson KC, Anderson J, Soiffer R, Freedman AS, Rabinowe SN, Robertson MJ, Spector N, Blake K, Murray C, Freeman A, Coral F, Marcus KC, Mauch P, Nadler LM, Ritz J: Monoclonal antibody-purged bone marrow transplantation therapy for multiple myeloma. Blood 82:2568, 1993
10. Seiden M, Schlossman R, Andersen J, Freeman A, Robertson M, Soiffer R, Freedman A, Mauch P, Ritz J, Nadler L, Anderson KC: Monoclonal antibody-purged bone marrow transplantation therapy for multiple myeloma. Leuk Lymphoma 17:87, 1995
11. Schiller G, Vescio R, Freytes C, Spitzer G, Sahebi F, Lee M, Wu CH, Cao J, Lee JC, Hong CH, Lichtenstein A, Lill M, Hall J, Berenson R, Berenson J: Transplantation of CD34 positive peripheral blood progenitor cells following high dose chemotherapy for patients with advanced multiple myeloma. Blood 86:390, 1995
12. + selected versus unselected autologous peripheral blood progenitor cell transplantation in multiple myeloma. Blood (in press)
13. + stem cells do not contain clonal myeloma cells. Blood 86:381, 1995